Anthony Fauci understood that making people like Sandy who are living with a disease part of the research process leads to better science. But the rest of the NIH still hasn’t gotten the message.
Registration for the 36th International Symposium on ALS/MND is open! We are very much looking forward to once again meeting in person and are delighted…
This is “PanelNadiaThosMichael20240812” by M. C. C. on Vimeo, the home for high quality videos and the people who love them.
The U.S. has long been the global leader in biopharmaceutical innovation, investing in research and development that has led to breakthrough treatments and life-saving medications…
This is “Introduction to ALL ALS” by David Shulman on Vimeo, the home for high quality videos and the people who love them.
How a Swiss pharma giant built the last great corporate research skunkworks – and why that model may never work again.
AI is poised to transform healthcare, but lack of trust, transparency, or modernized consent could impede its progress. In the first article of a new…
Email from ICER Weekly View View as Webpage Sign up for ICER’s Weekly View Newsletter Weekly View August 1, 2025 From the desk of…
Neuvivo, Inc., a late-stage biopharmaceutical company developing treatments for neurodegenerative disease, today announced it has gained alignment with the U…
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease affecting the adult motor system, with no effective treatments available. Despite extensive research efforts, the exact…
